REGULUS THERAPEUTICS
Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines based on microRNAs. The discovery of MicroRNA in humans is one of the most exciting scientific breakthroughs in the last decade. MicroRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. It was founded in 2007 and is headquartered in Carlsbad, California.
REGULUS THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2007-09-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.regulusrx.com
Total Employee:
51+
Status:
Active
Contact:
858-202-6300
Total Funding:
361.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Font Awesome Nginx Microsoft Exchange Online
Similar Organizations
Xilio Therapeutics
Xilio Therapeutics is a biopharmaceutical company focused on developing highly-potent, targeted immuno-oncology therapeutics.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Ayala Pharmaceuticals
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).
BioTheryX
BioTheryX is a clinical-stage biopharmaceutical company that focuses on the development of therapies for hematological malignancies.
Brooklyn ImmunoTherapeutics
Brooklyn ImmunoTherapeutics is a clinical=stage biopharmaceutical company discovers and develops a novel cytokine-based therapy.
Cascadian Therapeutics
Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.
CohBar
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.
Crestone
Crestone is a clinical stage biopharmaceutical company focused on inventing and developing novel mechanism.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eloxx
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
Idun Pharmaceuticals
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control
Kind Pharmaceutical
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.
Liquidia Technologies
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Motif BioSciences
Motif BioSciences, a population genetics company, focuses on the genetic causes of major diseases using human genetic data from individuals.
Rafael Holdings
Rafael Holdings is a company focused on the development of novel cancer therapies.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Renova Therapeutics
Renova Therapeutics is an industry leader in the emerging field of gene therapy, pursuing the development of treatments.
Seres Therapeutics
Seres Therapeutics is a microbiome therapeutics company.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
StemTek Therapeutics
StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment.
Tetra Therapeutics
Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products.
Vanda Pharmaceuticals
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Zymenex
Zymenex is a Scandinavian biopharmaceutical company focused on the development and commercialization of novel enzyme replacement therapies
Current Advisors List
Board_member
2009-01-01
Board_member
Board_member
Current Employees Featured
Jay Hagan President, CEO & Director @ Regulus Therapeutics
President, CEO & Director
2017-05-01
Peter S. Linsley CTO @ Regulus Therapeutics
CTO
Simos Simeonidis Director Board Of Directors @ Regulus Therapeutics
Director Board Of Directors
2019-06-01
Cris Calsada Chief Financial Officer @ Regulus Therapeutics
Chief Financial Officer
2019-08-01
Mohammad Ahmadian VP of Chemistry & Pharmaceutical Development @ Regulus Therapeutics
VP of Chemistry & Pharmaceutical Development
2021-12-01
Brian Campion Vice President, Business Development @ Regulus Therapeutics
Vice President, Business Development
2020-07-01
Denis Drygin Chief Scientific Officer @ Regulus Therapeutics
Chief Scientific Officer
2020-08-01
Amin Kamel Vice President of DMPK @ Regulus Therapeutics
Vice President of DMPK
2022-01-01
Stock Details
Investors List
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Regulus Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Regulus Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Regulus Therapeutics
Sanofi
Sanofi investment in Funding Round - Regulus Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | Regulus Therapeutics Names VP |
| 2021-12-03 | Regulus Therapeutics Names VP |
Official Site Inspections
http://www.regulusrx.com
- Host name: 234.80.154.104.bc.googleusercontent.com
- IP address: 104.154.80.234
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Regulus Therapeutics"
Overview - Regulus Therapeutics
Apr 2, 2025 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today...See details»
Regulus Therapeutics Enters into Agreement to be Acquired by …
Apr 30, 2025 Novartis to acquire Regulus for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent value right, for a total equity value …See details»
Board of Directors - Regulus Therapeutics
Stelios Papadopoulos, Ph.D. Stelios Papadopoulos, Ph.D. Chair of the board, has served on our board of directors since our conversion to a corporation in January 2009 and as our Chair …See details»
Regulus Therapeutics - Wikipedia
In April 2008, Regulus and GlaxoSmithKline (GSK) entered into a microRNA-focused strategic alliance for the discovery, development and commercialization of novel microRNA-targeted …See details»
Novartis to acquire Regulus Therapeutics and farabursen, an ...
Apr 30, 2025 Patient organization funding Patients perspectives stories Patients and caregivers. Information for patients and their caregivers including clinical trial recruiting, managed access …See details»
Regulus Therapeutics - Crunchbase Company Profile & Funding
Contact Email info@regulusrx.com Phone Number 858-202-6300 Regulus Therapeutics Is a biopharmaceutical company leading the discovery of a new class of high-impact medicines …See details»
Regulus Therapeutics
Mar 27, 2025 Regulus Therapeutics is dedicated to developing life-changing therapeutics for patients with orphan kidney diseases.See details»
Regulus Therapeutics - Craft
Regulus Therapeutics has 4 employees at their 1 location and $10.01 m in annual revenue in FY 2020. See insights on Regulus Therapeutics including office locations, competitors, revenue, …See details»
Regulus Therapeutics (USA) Funding: $480.9M - Medical Startups
Apr 2, 2025 Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on...See details»
Regulus Therapeutics Enters into Agreement to be Acquired by …
Apr 30, 2025 Novartis to acquire Regulus for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent value right, for a total equity value …See details»
Regulus Therapeutics
Apr 9, 2025 Regulus was founded in 2007 by Alnylam Pharmaceuticals, Isis Pharmaceuticals and the Cystic Fibrosis Foundation to create novel medicines targeting microRNAs, which are …See details»
Corporate Governance - Regulus Therapeutics
The Board of Directors of Regulus Therapeutics Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
Regulus Therapeutics, Inc. (Regulus Therapeutics, Inc.) - 药物管线_ …
Mar 8, 2025 To access the call, please dial (833) 816-1394 (domestic) or (412) 317-0487 (international). To access the telephone replay of the call, dial (877) 344-7529 (domestic) or …See details»
Regulus Therapeutics - Overview, News & Similar companies
May 9, 2024 Regulus Therapeutics contact info: Phone number: (858) 202-6300 Website: www.regulusrx.com What does Regulus Therapeutics do? Regulus Therapeutics Inc., a …See details»
Regulus Therapeutics Enters into Agreement to be Acquired by …
Previous: Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech SummitSee details»
Regulus Therapeutics Inc. - Cruelty Free Investing
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
Patients - Regulus Therapeutics
The NKF is a major non-profit health organization focused on awareness, education, prevention and treatment of kidney disease. www.kidney.org NORD, along with its more than 300 patient …See details»
Press Releases - Regulus Therapeutics
Nov 26, 2024 Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of …See details»
RegulusRx - YouTube
Regulus Therapeutics Inc. is a biopharmaceutical company leading the discovery and development of a new class of high-impact medicines based on microRNAs. Re...See details»
Regulus Therapeutics Reports Fourth Quarter and Year-End 2024 …
Dec 31, 2024 Positive topline results from an interim analysis of the fourth cohort of patients in the Phase 1b multiple-ascending dose (MAD) clinical trial of farabursen (RGLS8429) for the …See details»